Linglan Tu
Impact in
- Pharmaceutical Science top 10%
- Advanced Drug Delivery Systems
-
- Cancer-related molecular mechanisms research
Papers in
-
- Protein Tyrosine Phosphatases 3
- Ubiquitin and proteasome pathways 2
- RNA Interference and Gene Delivery 2
- Oncology 9
- Metal complexes synthesis and properties 4
- Co-authors
- Xiaoliang Zheng (21 shared papers)Dongmei Yan (5 shared papers)Lina Yin (4 shared papers)Jingjing Zhang (3 shared papers)Shirong Zhang (3 shared papers)Xiaoju Wang (6 shared papers)Laijin Tian (5 shared papers)Guang Liang (6 shared papers)
- Journals
- Applied Organometallic Chemistry (3 papers)Cellular Signalling (2 papers)Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2 papers)European Journal of Medicinal Chemistry (2 papers)Biomedicine & Pharmacotherapy (2 papers)
- Partner nations
- China
In The Last Decade
Linglan Tu
34 papers receiving 403 citations
Peers
Comparison fields: 5 of 73
- Pharmaceutical Science 30
- Cancer Research 50
- Oncology 79
- Inorganic Chemistry 44
- Molecular Biology 176
Countries citing papers authored by Linglan Tu
This map shows the geographic impact of Linglan Tu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linglan Tu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linglan Tu more than expected).
Fields of papers citing papers by Linglan Tu
This network shows the impact of papers produced by Linglan Tu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linglan Tu. The network helps show where Linglan Tu may publish in the future.
Co-authors
The 25 scholars most cited alongside Linglan Tu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 61 | |
| 2 | 2017 | 43 | |
| 3 | 2021 | 24 | |
| 4 | 2023 | 23 | |
| 5 | 2011 | 22 | |
| 6 | 2023 | 22 | |
| 7 | 2021 | 21 | |
| 8 | 2023 | 19 | |
| 9 | 2008 | 19 | |
| 10 | 2018 | 16 | |
| 11 | 2013 | 12 | |
| 12 | 2022 | 11 | |
| 13 | 2023 | 11 | |
| 14 | 2023 | 9 | |
| 15 | 2023 | 9 | |
| 16 | 2017 | 9 | |
| 17 | 2024 | 9 | |
| 18 | 2011 | 7 | |
| 19 | 2024 | 7 | |
| 20 | 2022 | 6 |
About Linglan Tu
Linglan Tu is a scholar working on Molecular Biology, Oncology, Inorganic Chemistry, Organic Chemistry and Cell Biology, having authored 35 papers that have together received 404 indexed citations. Recurring topics across this work include Organometallic Compounds Synthesis and Characterization (5 papers), Crystal structures of chemical compounds (5 papers), Advanced Drug Delivery Systems (4 papers), Metal complexes synthesis and properties (4 papers), Protein Tyrosine Phosphatases (3 papers), Ubiquitin and proteasome pathways (2 papers), Drug Solubulity and Delivery Systems (2 papers) and RNA Interference and Gene Delivery (2 papers). The work is most often cited by research in Pharmaceutical Science (30 citations), Cancer Research (50 citations), Oncology (79 citations), Inorganic Chemistry (44 citations) and Molecular Biology (176 citations). Linglan Tu has collaborated with scholars based in China. Frequent co-authors include Xiaoliang Zheng, Dongmei Yan, Lina Yin, Jingjing Zhang, Shirong Zhang, Xiaoju Wang, Laijin Tian, Dongmei Yan, Guang Liang and Lucheng Zhu. Their work appears in journals such as Applied Organometallic Chemistry, Cellular Signalling, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, European Journal of Medicinal Chemistry and Biomedicine & Pharmacotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.